Harbin Gloria Pharmaceuticals

Harbin Gloria Pharmaceuticals is a company listed under the stock ticker 002437 (CN).

View the org chart displaying its 16 main executives

Most searched biographies at Harbin Gloria Pharmaceuticals

• Leifeng Guo, Chief Executive Officer
• Jin Hu, Chairman of the Board
• Hui Xue, Independent Director

Create your alert
to follow the executive moves at Harbin Gloria Pharmaceuticals.

Harbin Gloria Pharmaceuticals has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Danilo Cicmil - Supervisory Board Member at Galenika
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Harbin Gloria Pharmaceuticals

Social media about Harbin Gloria Pharmaceuticals

• Harbin Gloria Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Harbin Gloria Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Zuozhe Ji

Call Harbin Gloria Pharmaceuticals at +86 451 ...

View the org chart

Register to receive your alert

Report an error